Basal cell adenoma and pleomorphic adenoma of the parotid gland: a single center experience.


Journal

Minerva surgery
ISSN: 2724-5438
Titre abrégé: Minerva Surg
Pays: Italy
ID NLM: 101777295

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 11 12 2023
pubmed: 2 8 2023
entrez: 2 8 2023
Statut: ppublish

Résumé

Basal cell adenoma (BCA) and pleomorphic adenoma (PA) are among the most common benign neoplasms of the salivary glands. The aim of this study was to analyze and compare the diagnosis, treatment, and recurrence rate of these two different types of parotid benign tumors. A retrospective analysis of all cases of parotid gland BCA and PA surgically treated between January 1, 1990, and December 31, 2019, was performed at our university. A total of 349 patients were enrolled in the present study, 311 of which (89.1%) were affected by PA, and 38 patients (10.9%) by BCA. The most frequently performed surgery was partial parotidectomy for both groups (85.9% in PA and 65.8% in BCA). Perioperative complications - often transient and of short duration - occurred within 48 hours of surgery and were observed in 30.6% of PA patients and in 18.4% of BCA patients; furthermore, recurrences were noticed in 19 PA patients (6.2%) and in 3 BCA patients (7.9%) (rates in range with the available literature data). To the best of our knowledge, this study is one of the largest single-center series in the literature comparing diagnosis, treatment, recurrence rate and clinical-pathological features of two different types of benign parotid gland tumors, BCA, and PA.

Sections du résumé

BACKGROUND BACKGROUND
Basal cell adenoma (BCA) and pleomorphic adenoma (PA) are among the most common benign neoplasms of the salivary glands. The aim of this study was to analyze and compare the diagnosis, treatment, and recurrence rate of these two different types of parotid benign tumors.
METHODS METHODS
A retrospective analysis of all cases of parotid gland BCA and PA surgically treated between January 1, 1990, and December 31, 2019, was performed at our university.
RESULTS RESULTS
A total of 349 patients were enrolled in the present study, 311 of which (89.1%) were affected by PA, and 38 patients (10.9%) by BCA. The most frequently performed surgery was partial parotidectomy for both groups (85.9% in PA and 65.8% in BCA). Perioperative complications - often transient and of short duration - occurred within 48 hours of surgery and were observed in 30.6% of PA patients and in 18.4% of BCA patients; furthermore, recurrences were noticed in 19 PA patients (6.2%) and in 3 BCA patients (7.9%) (rates in range with the available literature data).
CONCLUSIONS CONCLUSIONS
To the best of our knowledge, this study is one of the largest single-center series in the literature comparing diagnosis, treatment, recurrence rate and clinical-pathological features of two different types of benign parotid gland tumors, BCA, and PA.

Identifiants

pubmed: 37530711
pii: S2724-5691.23.09876-3
doi: 10.23736/S2724-5691.23.09876-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

626-632

Auteurs

Chiara Bianchini (C)

Ear, Nose and Throat (ENT), and Audiology Unit, Department of Neurosciences, University Hospital of Ferrara, Ferrara, Italy.

Marco Brugali (M)

Ear, Nose and Throat (ENT), and Audiology Unit, Department of Neurosciences, University Hospital of Ferrara, Ferrara, Italy.

Andrea Migliorelli (A)

Ear, Nose and Throat (ENT), and Audiology Unit, Department of Neurosciences, University Hospital of Ferrara, Ferrara, Italy.

Virginia Corazzi (V)

Ear, Nose and Throat (ENT), and Audiology Unit, Department of Neurosciences, University Hospital of Ferrara, Ferrara, Italy.

Giovanni Cammaroto (G)

Ear, Nose and Throat (ENT) Unit, Morgagni Pierantoni Hospital, AUSL Romagna, Forlì, Forlì-Cesena, Italy.

Giuseppe Meccariello (G)

Ear, Nose and Throat (ENT) Unit, Morgagni Pierantoni Hospital, AUSL Romagna, Forlì, Forlì-Cesena, Italy.

Francesco Stomeo (F)

Ear, Nose and Throat (ENT), and Audiology Unit, Department of Neurosciences, University Hospital of Ferrara, Ferrara, Italy.

Andrea Ciorba (A)

Ear, Nose and Throat (ENT), and Audiology Unit, Department of Neurosciences, University Hospital of Ferrara, Ferrara, Italy - andrea.ciorba@unife.it.

Stefano Pelucchi (S)

Ear, Nose and Throat (ENT), and Audiology Unit, Department of Neurosciences, University Hospital of Ferrara, Ferrara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH